Mingbo Su

机构：Chinese Academy of Sciences, Shanghai Institute of Materia Medica

发表论文 52 篇 · 总被引 1604 次 · h-index 25

代表论文

Triazine-Based Covalent DNA-Encoded Libraries for Discovery of Covalent Inhibitors of Target Proteins (2022 · ACS Medicinal Chemistry Letters · 被引 47)
Synthesis and in Vitro and in Vivo Biological Evaluation of Tissue-Specific Bisthiazole Histone Deacetylase (HDAC) Inhibitors (2019 · Journal of Medicinal Chemistry · 被引 40)
Discovery of a Potent and Selective NF-κB-Inducing Kinase (NIK) Inhibitor That Has Anti-inflammatory Effects in Vitro and in Vivo (2020 · Journal of Medicinal Chemistry · 被引 38)
Structure–Activity Relationship Study of Indolin-5-yl-cyclopropanamine Derivatives as Selective Lysine Specific Demethylase 1 (LSD1) Inhibitors (2022 · Journal of Medicinal Chemistry · 被引 34)
High-throughput screening of SARS-CoV-2 main and papain-like protease inhibitors (2022 · Protein & Cell · 被引 30)
Discovery of a Natural-Product-Derived Preclinical Candidate for Once-Weekly Treatment of Type 2 Diabetes (2019 · Journal of Medicinal Chemistry · 被引 28)